Lucia Tornaghi
- Hematology top 5%
- Genetics top 5%
- Rheumatology top 10%
- Oncology
- Molecular Biology
- Co-authors
- Carlo Gambacorti‐PasseriniGianmarco CorneoEnrico PoglianiMassimo ZucchettiMaurizio D’IncalciRoberta FrapolliSilvia BungaroPietro Pioltelli
- Topics
- Chronic Myeloid Leukemia Treatments (12 papers)Chronic Lymphocytic Leukemia Research (10 papers)Eosinophilic Disorders and Syndromes (6 papers)
- Cited by
- HematologyGeneticsRheumatology
- Journals
- The LancetBloodTransfusion
- Partner nations
- ItalyUnited StatesSwitzerland
In The Last Decade
Lucia Tornaghi
12 papers receiving 334 citations
Peers
Comparison fields: 5 of 52
- Hematology 245
- Genetics 170
- Rheumatology 125
- Oncology 68
- Molecular Biology 61
Countries citing papers authored by Lucia Tornaghi
This map shows the geographic impact of Lucia Tornaghi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lucia Tornaghi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lucia Tornaghi more than expected).
Fields of papers citing papers by Lucia Tornaghi
This network shows the impact of papers produced by Lucia Tornaghi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lucia Tornaghi. The network helps show where Lucia Tornaghi may publish in the future.
Co-authorship network of co-authors of Lucia Tornaghi
This figure shows the co-authorship network connecting the top 25 collaborators of Lucia Tornaghi. A scholar is included among the top collaborators of Lucia Tornaghi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lucia Tornaghi. Lucia Tornaghi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 19 | |
| 3 | 17 | |
| 4 | Imatinib failed to eradicate chronic myeloid leukemia in a patient with minimal residual disease. | 2 |
| 5 | 7 | |
| 6 | 3 | |
| 7 | 7 | |
| 8 | Mechanisms of resistance to imatinib in chronic myeloid leukemia (CML) patients in chronic phase (CP) who achieved durable complete cytogenetic responses (CCR) | 1 |
| 9 | 76 | |
| 10 | Alpha1 acid glycoprotein binds to imatinib (STI571) and substantially alters its pharmacokinetics in chronic myeloid leukemia patients. | 182 |
| 11 | 24 | |
| 12 | STI571 administered to chronic myeloid leukemia (CML) patients inhibits cell proliferation, induces apoptosis and initially causes partial inhibition of BCR/ABL autophosphorylation | 2 |
About Lucia Tornaghi
Lucia Tornaghi is a scholar working on Hematology, Genetics and Rheumatology, having authored 12 papers that have together received 343 indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (12 papers), Chronic Lymphocytic Leukemia Research (10 papers) and Eosinophilic Disorders and Syndromes (6 papers). The work is most often cited by research in Hematology (245 citations), Genetics (170 citations) and Rheumatology (125 citations). Lucia Tornaghi has collaborated with scholars based in Italy, United States and Switzerland. Frequent co-authors include Carlo Gambacorti‐Passerini, Gianmarco Corneo, Enrico Pogliani, Massimo Zucchetti, Maurizio D’Incalci, Roberta Frapolli, Silvia Bungaro, Pietro Pioltelli, Magda Verga and Fabio Rossi. Their work appears in journals such as The Lancet, Blood and Transfusion.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.